Rapid Micro Biosystems (RPID) Total Debt (2020 - 2026)
Rapid Micro Biosystems recorded quarterly Total Debt of $19.1 million in Q1 2026, up 0.8% quarter-over-quarter from $18.9 million in Q4 2025.
Rapid Micro Biosystems' Total Debt history runs 4 years deep, the most recent figure standing at $19.1 million for Q1 2026.
- In Q1 2026, Total Debt changed N/A year-over-year to $19.1 million; the TTM figure through Mar 2026 stood at $19.1 million (changed N/A YoY), while the FY2025 annual figure was $18.9 million, changed N/A from the prior year.
- Total Debt came in at $19.1 million for Q1 2026 at Rapid Micro Biosystems, up from $18.9 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $19.1 million in Q1 2026 to a low of $18.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 34.05 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.72 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 28.07 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 11.03 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 1.93 Bn |
| 10 | Rapid Micro Biosystems | 89.50 Mn | 66.56 Mn | 371,000.00 | 19.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.05 Mn |
| Dec 31, 2025 | 18.90 Mn |
| Sep 30, 2025 | 18.83 Mn |
| Jun 30, 2021 | 24.98 Mn |
| Dec 31, 2020 | 24.81 Mn |